251 related articles for article (PubMed ID: 25451156)
1. Glycogen synthase kinase 3α deficiency attenuates atherosclerosis and hepatic steatosis in high fat diet-fed low density lipoprotein receptor-deficient mice.
Banko NS; McAlpine CS; Venegas-Pino DE; Raja P; Shi Y; Khan MI; Werstuck GH
Am J Pathol; 2014 Dec; 184(12):3394-404. PubMed ID: 25451156
[TBL] [Abstract][Full Text] [Related]
2. Characterizing the Role of Glycogen Synthase Kinase-3α/β in Macrophage Polarization and the Regulation of Pro-Atherogenic Pathways in Cultured Ldlr
Patel S; Werstuck G
Front Immunol; 2021; 12():676752. PubMed ID: 34394077
[TBL] [Abstract][Full Text] [Related]
3. 4-phenylbutyrate and valproate treatment attenuates the progression of atherosclerosis and stabilizes existing plaques.
Huang A; Young TL; Dang VT; Shi Y; McAlpine CS; Werstuck GH
Atherosclerosis; 2017 Nov; 266():103-112. PubMed ID: 29024862
[TBL] [Abstract][Full Text] [Related]
4. Deletion of Myeloid GSK3α Attenuates Atherosclerosis and Promotes an M2 Macrophage Phenotype.
McAlpine CS; Huang A; Emdin A; Banko NS; Beriault DR; Shi Y; Werstuck GH
Arterioscler Thromb Vasc Biol; 2015 May; 35(5):1113-22. PubMed ID: 25767272
[TBL] [Abstract][Full Text] [Related]
5. Deletion of Macrophage-Specific Glycogen Synthase Kinase (GSK)-3α Promotes Atherosclerotic Regression in
Patel S; Mastrogiacomo L; Fulmer M; Shi Y; Werstuck GH
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012557
[TBL] [Abstract][Full Text] [Related]
6. Curcumin modulation of high fat diet-induced atherosclerosis and steatohepatosis in LDL receptor deficient mice.
Hasan ST; Zingg JM; Kwan P; Noble T; Smith D; Meydani M
Atherosclerosis; 2014 Jan; 232(1):40-51. PubMed ID: 24401215
[TBL] [Abstract][Full Text] [Related]
7. Endoplasmic reticulum stress and glycogen synthase kinase-3β activation in apolipoprotein E-deficient mouse models of accelerated atherosclerosis.
McAlpine CS; Bowes AJ; Khan MI; Shi Y; Werstuck GH
Arterioscler Thromb Vasc Biol; 2012 Jan; 32(1):82-91. PubMed ID: 21998135
[TBL] [Abstract][Full Text] [Related]
8. Investigating the Role of Endothelial Glycogen Synthase Kinase3α/β in Atherogenesis in Low Density Lipoprotein Receptor Knockout Mice.
Mastrogiacomo L; Werstuck GH
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499109
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine-1-Phosphate Receptor 1, Expressed in Myeloid Cells, Slows Diet-Induced Atherosclerosis and Protects against Macrophage Apoptosis in Ldlr KO Mice.
Gonzalez L; Qian AS; Tahir U; Yu P; Trigatti BL
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29244772
[TBL] [Abstract][Full Text] [Related]
10. Adipose tissue deficiency results in severe hyperlipidemia and atherosclerosis in the low-density lipoprotein receptor knockout mice.
Wang M; Gao M; Liao J; Qi Y; Du X; Wang Y; Li L; Liu G; Yang H
Biochim Biophys Acta; 2016 May; 1861(5):410-8. PubMed ID: 26921684
[TBL] [Abstract][Full Text] [Related]
11. High fat / high cholesterol diet does not provoke atherosclerosis in the ω3-and ω6-polyunsaturated fatty acid synthesis-inactivated Δ6-fatty acid desaturase-deficient mouse.
Stoffel W; Binczek E; Schmidt-Soltau I; Brodesser S; Wegner I
Mol Metab; 2021 Dec; 54():101335. PubMed ID: 34530175
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase R-like endoplasmic reticulum kinase and glycogen synthase kinase-3α/β regulate foam cell formation.
McAlpine CS; Werstuck GH
J Lipid Res; 2014 Nov; 55(11):2320-33. PubMed ID: 25183803
[TBL] [Abstract][Full Text] [Related]
13. Hepatic Overexpression of Soluble Urokinase Receptor (uPAR) Suppresses Diet-Induced Atherosclerosis in Low-Density Lipoprotein Receptor-Deficient (LDLR-/-) Mice.
Larmann J; Jurk K; Janssen H; Müller M; Herzog C; Lorenz A; Schmitz M; Nofer JR; Theilmeier G
PLoS One; 2015; 10(8):e0131854. PubMed ID: 26313756
[TBL] [Abstract][Full Text] [Related]
14. Low carbohydrate, high protein diet promotes atherosclerosis in apolipoprotein E/low-density lipoprotein receptor double knockout mice (apoE/LDLR(-/-)).
Kostogrys RB; Franczyk-Żarów M; Maślak E; Gajda M; Mateuszuk L; Jackson CL; Chłopicki S
Atherosclerosis; 2012 Aug; 223(2):327-31. PubMed ID: 22771189
[TBL] [Abstract][Full Text] [Related]
15. The effects of diet on occlusive coronary artery atherosclerosis and myocardial infarction in scavenger receptor class B, type 1/low-density lipoprotein receptor double knockout mice.
Fuller M; Dadoo O; Serkis V; Abutouk D; MacDonald M; Dhingani N; Macri J; Igdoura SA; Trigatti BL
Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2394-403. PubMed ID: 25212235
[TBL] [Abstract][Full Text] [Related]
16. Obesity potentiates development of fatty liver and insulin resistance, but not atherosclerosis, in high-fat diet-fed agouti LDLR-deficient mice.
Coenen KR; Hasty AH
Am J Physiol Endocrinol Metab; 2007 Aug; 293(2):E492-9. PubMed ID: 17566116
[TBL] [Abstract][Full Text] [Related]
17. Insulin-degrading enzyme deficiency in bone marrow cells increases atherosclerosis in LDL receptor-deficient mice.
Caravaggio JW; Hasu M; MacLaren R; Thabet M; Raizman JE; Veinot JP; Marcel YL; Milne RW; Whitman SC
Cardiovasc Pathol; 2013; 22(6):458-64. PubMed ID: 23684818
[TBL] [Abstract][Full Text] [Related]
18. Hepatic insulin signaling regulates VLDL secretion and atherogenesis in mice.
Han S; Liang CP; Westerterp M; Senokuchi T; Welch CL; Wang Q; Matsumoto M; Accili D; Tall AR
J Clin Invest; 2009 Apr; 119(4):1029-41. PubMed ID: 19273907
[TBL] [Abstract][Full Text] [Related]
19. Angiotensinogen Exerts Effects Independent of Angiotensin II.
Lu H; Wu C; Howatt DA; Balakrishnan A; Moorleghen JJ; Chen X; Zhao M; Graham MJ; Mullick AE; Crooke RM; Feldman DL; Cassis LA; Vander Kooi CW; Daugherty A
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):256-65. PubMed ID: 26681751
[TBL] [Abstract][Full Text] [Related]
20. Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice.
Nuotio-Antar AM; Hachey DL; Hasty AH
Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1517-28. PubMed ID: 17878220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
